Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP426228.RAQ9Kt1jI1HLczOg8BfbgX3aGHN5Yz-T-JG0_acFw3pFk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP426228.RAQ9Kt1jI1HLczOg8BfbgX3aGHN5Yz-T-JG0_acFw3pFk130_assertion type Assertion NP426228.RAQ9Kt1jI1HLczOg8BfbgX3aGHN5Yz-T-JG0_acFw3pFk130_head.
- NP426228.RAQ9Kt1jI1HLczOg8BfbgX3aGHN5Yz-T-JG0_acFw3pFk130_assertion description "[Thus, the ability to activate AMPK after treatment with tyrosine kinase inhibitors may be a crucial factor for increased efficacy against the tumor and decreased risk of cardiomyopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP426228.RAQ9Kt1jI1HLczOg8BfbgX3aGHN5Yz-T-JG0_acFw3pFk130_provenance.
- NP426228.RAQ9Kt1jI1HLczOg8BfbgX3aGHN5Yz-T-JG0_acFw3pFk130_assertion evidence source_evidence_literature NP426228.RAQ9Kt1jI1HLczOg8BfbgX3aGHN5Yz-T-JG0_acFw3pFk130_provenance.
- NP426228.RAQ9Kt1jI1HLczOg8BfbgX3aGHN5Yz-T-JG0_acFw3pFk130_assertion SIO_000772 18594201 NP426228.RAQ9Kt1jI1HLczOg8BfbgX3aGHN5Yz-T-JG0_acFw3pFk130_provenance.
- NP426228.RAQ9Kt1jI1HLczOg8BfbgX3aGHN5Yz-T-JG0_acFw3pFk130_assertion wasDerivedFrom befree-20140225 NP426228.RAQ9Kt1jI1HLczOg8BfbgX3aGHN5Yz-T-JG0_acFw3pFk130_provenance.
- NP426228.RAQ9Kt1jI1HLczOg8BfbgX3aGHN5Yz-T-JG0_acFw3pFk130_assertion wasGeneratedBy ECO_0000203 NP426228.RAQ9Kt1jI1HLczOg8BfbgX3aGHN5Yz-T-JG0_acFw3pFk130_provenance.